Internal Medicine, Hematology & Oncology · Stuart, FL
NPI
1336135102
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
501 SE Osceola St, Suite 301
Stuart, FL, 34994
Phone (772) 223-5955
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.3M
231,363 services
Medicare patients, 2024
541
Average age 77
Drug cost, 2024
$7.3M
1,467 prescriptions
Company payments, 2025
$6,216
From 45 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Prashant R Patel was code J1439 (injection, ferric carboxymaltose, 1 mg), 77,250 times for 45 patients. In total Prashant R Patel billed 231,363 services in 144 codes, and Medicare paid $3.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-11-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 77,250 | 45 | $0.87 | $68K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 7,120 | 18 | $2.37 | $17K |
| J0897 Injection, denosumab, 1 mg | Office | 5,160 | 18 | $20.20 | $104K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,732 | 33 | $0.09 | $329 |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2,840 | 12 | $6.52 | $19K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 1,900 | 16 | $0.10 | $197 |
| 85025 Blood Count | Office | 1,765 | 393 | $7.58 | $13K |
| 36415 Venipuncture Blood Collection | Office | 1,124 | 327 | $8.65 | $9,723 |
| 99214 Office E&M - Established | Office | 997 | 309 | $100.22 | $100K |
| 80053 Clinical Chemistry | Office | 853 | 329 | $10.33 | $8,808 |
| 96372 Injection Administration | Office | 507 | 72 | $11.45 | $5,804 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 495 | 13 | $0.51 | $254 |
| 82746 Clinical Chemistry | Office | 364 | 194 | $14.37 | $5,231 |
| 82607 Clinical Chemistry | Office | 356 | 194 | $14.74 | $5,247 |
| 82728 Clinical Chemistry | Office | 356 | 184 | $13.32 | $4,743 |
By year: 2022 $4.3M for 228,573 services; 2023 $4.2M for 255,887 services; 2024 $3.3M for 231,363 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,765 | 393 | $7.58 | $13K |
| 36415 Venipuncture Blood Collection | 1,124 | 327 | $8.65 | $9,723 |
| 80053 Clinical Chemistry | 853 | 329 | $10.33 | $8,808 |
| 82746 Clinical Chemistry | 364 | 194 | $14.37 | $5,231 |
| 82728 Clinical Chemistry | 356 | 184 | $13.32 | $4,743 |
| 82607 Clinical Chemistry | 356 | 194 | $14.74 | $5,247 |
| 83540 Clinical Chemistry | 138 | 104 | $6.34 | $875 |
| 83550 Clinical Chemistry | 134 | 101 | $8.57 | $1,148 |
| 82378 Clinical Chemistry | 93 | 51 | $18.58 | $1,728 |
| 84153 Clinical Chemistry | 75 | 35 | $18.02 | $1,352 |
Medicare prescription drug claims, 2024
In 2024, the drug Prashant R Patel prescribed most often to Medicare patients was Xtandi (Enzalutamide), with 71 prescriptions and refills. In total Prashant R Patel wrote 1,467 Medicare prescriptions that cost $7.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xtandi Enzalutamide | 71 | 71 | Under 11 | $996K |
| Procrit Epoetin Alfa | 67 | 67 | 23 | $179K |
| Venclexta Venetoclax | 54 | 54 | 12 | $672K |
| Hydroxyurea Generic | 45 | 107 | 13 | $740 |
| Opdivo Nivolumab | 40 | 40 | Under 11 | $413K |
| Anagrelide Hcl Generic | 37 | 71 | Under 11 | $2,995 |
| Dexamethasone Generic | 35 | 35 | 16 | $946 |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 34 | 34 | Under 11 | $517K |
| Revlimid Lenalidomide | 33 | 33 | Under 11 | $448K |
| Abiraterone Acetate Generic | 32 | 32 | Under 11 | $24K |
| Orgovyx Relugolix | 30 | 30 | Under 11 | $77K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 29 | 29 | Under 11 | $696 |
| Prednisone Generic | 28 | 39 | Under 11 | $212 |
| Gabapentin Generic | 27 | 31 | Under 11 | $304 |
| Bortezomib Generic | 27 | 27 | Under 11 | $12K |
Brand drugs: 770 claims; generic drugs: 697 claims; opioid claims: 48.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Prashant R Patel $6,216 ($6,216 in general payments such as food, travel and fees) from 45 companies. The largest payer was Novartis Pharmaceuticals Corporation with $1,251.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 22 | $1,251 |
| Janssen Biotech, Inc. JNJ | 29 | $580 |
| Pfizer Inc. PFE | 35 | $543 |
| GlaxoSmithKline, LLC. GSK | 17 | $353 |
| Astellas Pharma US Inc 4503.T | 8 | $343 |
| BeOne Medicines USA, Inc. ONC | 10 | $321 |
| Abbvie Inc. ABBV | 17 | $304 |
| Seagen Inc. PFE | 3 | $275 |
| Daiichi Sankyo Inc. 4568.T | 11 | $220 |
| Merck Sharp & Dohme LLC MRK | 7 | $173 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.